XML 28 R17.htm IDEA: XBRL DOCUMENT
v3.25.3

Note 10 - Goodwill and Intangible Assets | 9 Months Ended
--- | ---
Sep. 30, 2025
Notes to Financial Statements |
Goodwill and Intangible Assets Disclosure [Text Block] | Note 10 - Goodwill and Intangible Assets Goodwill Annual impairment test During the third quarter of 2025, we completed our annual review of goodwill for potential impairment using a quantitative assessment for all of our reporting units. The fair value of each reporting unit was estimated using a weighting of a discounted cash flow model and prices of comparable businesses. As a result of this review, we concluded that the fair value of each reporting unit exceeded its carrying value and our goodwill was not impaired. The table below reflects our goodwill and changes in the carrying value:
(in thousands) |  |  |  |
Goodwill balance at December 31, 2024 |  | $ | 1,633 |
Impairment charge during 2025 |  |  | - |
Goodwill balance at September 30, 2025 |  | $ | 1,633 |
Goodwill before impairment |  | $ | 6,428 |
Accumulated impairment charge |  |  | (4,795 | )
Goodwill balance at September 30, 2025 |  | $ | 1,633 |
Indefinite-lived intangible assets Annual impairment test During the third quarter of 2025, we completed our annual review of indefinite-lived intangible assets for potential impairment using a quantitative assessment for all of our reporting units. The fair value of each asset was estimated using a weighting of a discounted cash flow model and prices of comparable businesses. As a result of this review, we concluded the carrying value of the MRI trade name exceeded its estimated fair value resulting in an impairment charge of $230 thousand which is reported on the line item "Goodwill and intangible asset impairment charge" on our Consolidated Statement of Operations. The following table reflects our indefinite-lived intangible assets:
|  | September 30, 2025 |  |  | December 31, 2024 |
(in thousands) |  | Gross |  |  | Accumulated impairment |  |  | Net |  |  | Gross |  |  | Accumulated impairment |  |  | Net |
Domain name |  |  | 2,226 |  |  |  | - |  |  |  | 2,226 |  |  |  | 2,226 |  |  |  | - |  |  |  | 2,226 |
Trade name |  |  | 3,580 |  |  |  | (1,470 | ) |  |  | 2,110 |  |  |  | 3,580 |  |  |  | (1,240 | ) |  |  | 2,340 |
Total indefinite-lived intangible assets |  | $ | 5,806 |  |  | $ | (1,470 | ) |  | $ | 4,336 |  |  | $ | 5,806 |  |  | $ | (1,240 | ) |  | $ | 4,566 |
Finite-lived intangible assets During the third quarter of 2025, we conducted a review of our finite-lived intangible assets for any indications of impairment. Also as part of this review we evaluated the estimated remaining useful life of the assets. As a result of this evaluation we revised the estimated useful life of the MRI franchise agreements from 15 years to 8 remaining years. This change in the estimated useful life will increase annual amortization expense by approximately $202 thousand. The related revision to the estimated remaining useful life is primarily attributable to industry and market conditions effecting the overall financial performance of the franchise base. The following table reflects our finite-lived intangible assets:
|  |  | September 30, 2025 |  |  | December 31, 2024 |
(in thousands except useful life) | Estimated useful life |  | Gross |  |  | Accumulated amortization |  |  | Net |  |  | Gross |  |  | Accumulated amortization |  |  | Net |
Franchise agreements | 8 to 15 years |  | $ | 25,556 |  |  | $ | (7,114 | ) |  | $ | 18,442 |  |  | $ | 25,556 |  |  | $ | (5,819 | ) |  | $ | 19,737 |
Purchased software | 7 years |  |  | 3,200 |  |  |  | (1,829 | ) |  |  | 1,371 |  |  |  | 3,200 |  |  |  | (1,486 | ) |  |  | 1,714 |
Internally developed software | 5 years |  |  | 3,125 |  |  |  | (1,432 | ) |  |  | 1,693 |  |  |  | 3,125 |  |  |  | (963 | ) |  |  | 2,162 |
Total finite-lived intangible assets |  | $ | 31,881 |  |  | $ | (10,375 | ) |  | $ | 21,506 |  |  | $ | 31,881 |  |  | $ | (8,268 | ) |  | $ | 23,613 |
Amortization expense related to intangible assets totaled approximately $713 thousand and $656 thousand for the three months ended September 30, 2025 and September 30, 2024, respectively, and approximately $2.1million and $2.0 million for the nine months ended September 30, 2025 and September 30, 2024, respectively,

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-30/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-20/tableOfContent + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration